Endologix endures FDA deadly warning over recall

Endologix recalled its AFX Introducer System back in May, and now the FDA has assigned its most serious warning to the catheter-insertion device, saying it could cause serious injury or death. The company launched the recall in response to reports that the device's dilator could break during implantation procedures, asking customers to cease using and distributing the product, and the FDA has designated the recall a Class I, used only when products put patients at serious risk. More

Suggested Articles

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.

The FDA has given Grail a green light to conduct the interventional study, and it has begun enrolling participants through the company’s R&D partners.

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.